#Pharma Novartis tests copy of Amgen's Enbrel in late-stage trial - chicagotribune http://t.co/39PnnXZKpE
June 24, 2013
/http%3A%2F%2Fsnsimages.tribune.com%2Fmedia%2Fphoto%2F2013-06%2F76424824.jpg)
Novartis tests copy of Amgen's Enbrel in late-stage trial
LONDON (Reuters) - Sandoz, the generics unit of Novartis, has launched a late-stage trial with its biosimilar version of Amgen's Enbrel, consolidating its leading position in developing cheaper copies of complex biotech drugs.